From Mdwiki ![]() |
Meningoccal C vaccine (MenC), is a meningitis vaccine that protects against Neisseria meningitidis type C.[1][2] It is available either combined with Haemophilus type b vaccine or with other types of meningitis, the MenACWY vaccine.[3] It has been shown to dramatically reduce cases of meningitis C to levels of almost none, when part of a routine vaccination schedule.[3]
Common side effects include redness, pain and swelling at the site of injection.[3] There may be a slight fever, feeling of not wanting to eat, a tummy upset, irritability and poor sleep.[3] [3] Rarely, there may be dizziness, high fever or fainting.
The first monovalent MenC was licensed in the UK in 1999 and entered routine vaccination schedules there form November of that year.[1] By 2001, MenC cases in the UK dropped 87% in those who received the vaccine.[1] It continued to be used as a monovalent vaccine until 2016.[3]
Categories: [Meningococcal vaccines] [Vaccines] [World Health Organization essential medicines (vaccines)]
ZWI signed: